CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

measles-rubella vaccine

Trade name: M-R-Vax

Vaccineapproved

Approved

Apr 22, 1971

Clinical trial activity

18 trials · 25 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
9
Phase 3
5
Phase 4
5

Earliest trial started Jan 1, 2013 (NCT01700621)

Timeline

1970s

  1. Apr 22, 1971

    Earliest FDA Approval

2010s

  1. Jan 1, 2017

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

Approval history

  • approvedApr 22, 1971

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • live attenuated measles and rubella combined vaccine
  • measles-rubella vaccine

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06816524N/AJul 1, 2025Jomo Kenyatta University of Agriculture and Technology, National Institute for Public Health and the Environment, RIVM, Holland, Radboud University, Swiss Federal Institute of Technology
NCT06879327Phase 2May 30, 2025PATH, Pharmassist Ltd
NCT06815835Phase 3Apr 1, 2025International Center for Diarrheal Disease Research, Zydus Discovery DMCC
NCT06663436Phase 2Nov 4, 2024GlaxoSmithKline
NCT06213506Phase 2Jan 15, 2024GlaxoSmithKline, Kwame Nkrumah University of Science and Technology
NCT06667206Phase 2Nov 15, 2023Johns Hopkins University, University of London, University of Oxford
NCT05771779Phase 3Oct 14, 2023Centers for Disease Control and Prevention (CDC), International Center for Diarrheal Disease Research
NCT05155579Phase 1Feb 28, 2022Malaria Research and Training Center, Bamako, Mali, University of Oxford
NCT05073003Phase 1/Phase 2 (Phase 2)Oct 6, 2021GlaxoSmithKline
NCT04394689Phase 1/Phase 2 (Phase 2)Oct 31, 2020Centers for Disease Control and Prevention (CDC), Government of the Gambia, Medical Research Council, Micron Biomedical, Inc
NCT04183114Phase 2/Phase 3 (Phase 3)Sep 3, 2019PT Bio Farma
NCT03148990Phase 2/Phase 3 (Phase 3)Jan 8, 2018Oswaldo Cruz Foundation
NCT03680417Phase 4Nov 16, 2017Airlangga University, PT Bio Farma
NCT02699099Phase 3May 10, 2017GlaxoSmithKline
NCT03071575Phase 4Mar 9, 2017Centers for Disease Control and Prevention (CDC), Government of Bangladesh, International Center for Diarrheal Disease Research
NCT02643433Phase 4Aug 1, 2015Centers for Disease Control and Prevention (CDC), Centers for Disease Control and Prevention, China, Government of China
NCT02153866Phase 4Dec 1, 2013China National Biotec Group Co., Ltd, Government of China
NCT01700621Phase 4Jan 1, 2013International Center for Diarrheal Disease Research, PATH
Showing 18 of 18 trials
Page 1 / 1

Organizations

Research & Development (25)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Centers for Disease Control and Prevention (CDC)Government4132015
GlaxoSmithKlineFor profit4422017
International Center for Diarrheal Disease ResearchAcademic/Hospital4222013
Government of ChinaGovernment2112013
PATHAcademic/Hospital2222013
PT Bio FarmaFor profit2222017
University of OxfordAcademic/Hospital2222022
Airlangga UniversityAcademic/Hospital1012017
Centers for Disease Control and Prevention, ChinaGovernment1112015
China National Biotec Group Co., LtdFor profit1012013
Government of BangladeshAcademic/Hospital1012017
Government of the GambiaAcademic/Hospital1012020
Johns Hopkins UniversityAcademic/Hospital1012023
Jomo Kenyatta University of Agriculture and TechnologyAcademic/Hospital1012025
Kwame Nkrumah University of Science and TechnologyAcademic/Hospital1012024
Malaria Research and Training Center, Bamako, MaliAcademic/Hospital1012022
Medical Research CouncilGovernment1012020
Micron Biomedical, IncFor profit1112020
National Institute for Public Health and the Environment, RIVM, HollandGovernment1012025
Oswaldo Cruz FoundationAcademic/Hospital1112018
25 organizations
Page 1 / 2